3.00
price down icon3.85%   -0.12
 
loading

Macrogenics Inc Azioni (MGNX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
43.40%
41.23
72.84 22.24 13.19 19.35
Cost Of Revenue
-
- - - 0.233
Operating Expenses
1.62%
53.32
54.20 59.00 55.82 71.96
Benefits Costs and Expenses
0.25%
56.16
56.02 58.39 55.82 27.63
Costs And Expenses
1.62%
53.32
54.20 59.00 55.82 72.19
Operating Income/Loss
164.91%
-12.10
18.64 -36.76 -42.62 -52.84
Income/Loss From Continuing Operations Before Tax
188.76%
-14.93
16.82 -36.15 -41.04 -8.281
Income Tax Expense/Benefit
-0.777
- 0.105 - -
Income/Loss From Continuing Operations After Tax
184.15%
-14.15
16.82 -36.25 -41.04 -15.42
Net Income/Loss
184.15%
-14.15
16.82 -36.25 -41.04 -15.42
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.93%
0.0425
63.23 63.14 62.97 0.0545
Diluted Average Shares
99.93%
0.0425
63.28 63.14 62.97 0.0545
Basic Earnings Per Share
181.48%
-0.22
0.27 -0.57 -0.65 -0.25
Diluted Earnings Per Share
181.48%
-0.22
0.27 -0.57 -0.65 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):